Oncoxin‑Viusid® may improve quality of life and survival in patients with hormone‑refractory prostate cancer undergoing onco‑specific treatments
2001 ◽
Vol 37
◽
pp. S218
◽
Keyword(s):
2008 ◽
Vol 14
(9)
◽
pp. 2763-2767
◽
2001 ◽
Vol 35
(4)
◽
pp. 288-294
◽
2002 ◽
Vol 1
(2)
◽
pp. 79-80
◽
2007 ◽
Vol 16
(4)
◽
pp. 571-575
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4688-4688
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 8095-8095